189 related articles for article (PubMed ID: 37931826)
1. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
3. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
[TBL] [Abstract][Full Text] [Related]
4. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
[TBL] [Abstract][Full Text] [Related]
5. Bioengineering bacterial outer membrane vesicles as vaccine platform.
Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
[TBL] [Abstract][Full Text] [Related]
6. Outer Membrane Vesicle Vaccine Platforms.
Micoli F; Adamo R; Nakakana U
BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane vesicles (OMVs) enabled bio-applications: A critical review.
Huang Y; Nieh MP; Chen W; Lei Y
Biotechnol Bioeng; 2022 Jan; 119(1):34-47. PubMed ID: 34698385
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens.
Francis IP; Lui X; Wetzler LM
Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622
[TBL] [Abstract][Full Text] [Related]
9. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
[TBL] [Abstract][Full Text] [Related]
10. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
Lei EK; Azmat A; Henry KA; Hussack G
Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
[TBL] [Abstract][Full Text] [Related]
12. OMV Vaccines and the Role of TLR Agonists in Immune Response.
Mancini F; Rossi O; Necchi F; Micoli F
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
[TBL] [Abstract][Full Text] [Related]
13. Characterization and proteomic analysis of outer membrane vesicles from a commensal microbe, Enterobacter cloacae.
Bhar S; Edelmann MJ; Jones MK
J Proteomics; 2021 Jan; 231():103994. PubMed ID: 33007464
[TBL] [Abstract][Full Text] [Related]
14. Outer membrane vesicles as platform vaccine technology.
van der Pol L; Stork M; van der Ley P
Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
[TBL] [Abstract][Full Text] [Related]
15. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
Daleke-Schermerhorn MH; Felix T; Soprova Z; Ten Hagen-Jongman CM; Vikström D; Majlessi L; Beskers J; Follmann F; de Punder K; van der Wel NN; Baumgarten T; Pham TV; Piersma SR; Jiménez CR; van Ulsen P; de Gier JW; Leclerc C; Jong WS; Luirink J
Appl Environ Microbiol; 2014 Sep; 80(18):5854-65. PubMed ID: 25038093
[TBL] [Abstract][Full Text] [Related]
16. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
[TBL] [Abstract][Full Text] [Related]
17. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
[TBL] [Abstract][Full Text] [Related]
18. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
[TBL] [Abstract][Full Text] [Related]
19. Gram-negative outer membrane vesicles in vaccine development.
Collins BS
Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane vesicles: A bacterial-derived vaccination system.
Lieberman LA
Front Microbiol; 2022; 13():1029146. PubMed ID: 36620013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]